About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Quarterly Journal of Nuclear Medicine and Molecular Imaging
›
top-articles
Quarterly Journal of Nuclear Medicine and Molecular Imaging
1.3
(top 50%)
impact factor
878
(top 20%)
papers
11.7K
(top 20%)
citations
45
(top 20%)
h
-index
1.3
(top 50%)
extended IF
949
all documents
12.1K
doc citations
59
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Bifunctional chelates for metal nuclides
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
102
2
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2011
101
3
Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
99
4
Prostate-specific membrane antigen as a target for cancer imaging and therapy
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2015
92
5
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2004
87
6
Labeled leukocyte imaging: current status and future directions
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2009
87
7
Dosimetry for treatment with radiolabelled somatostatin analogues. A review
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2010
85
8
Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2010
84
9
Biological subtypes of breast cancer: current concepts and implications for recurrence patterns
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2013
84
10
New PET radiopharmaceuticals beyond FDG for brain tumor imaging
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2012
82
11
Diagnosis and therapy of neuroendocrine tumours
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2010
76
12
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2011
76
13
A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2004
75
14
Imaging reporter genes for cell tracking with PET and SPECT
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2005
71
15
Lung metastases from differentiated thyroid carcinoma. A 40 years' experience
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2004
68
16
Imaging of infectious diseases using [18F] fluorodeoxyglucose PET
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
66
17
Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
66
18
Conventional and advanced magnetic resonance imaging in patients with high-grade glioma
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2018
63
19
Diagnostic flowcharts in osteomyelitis, spondylodiscitis and prosthetic joint infection
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2014
63
20
Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
61
21
CT radiomics and PET radiomics: ready for clinical implementation?
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2019
58
22
Assessing tumor hypoxia by positron emission tomography with Cu-ATSM
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2009
56
23
Radioimmunotherapy with alpha-particle emitting radionuclides
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2004
55
24
Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2010
55
25
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2006
54
26
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2011
54
27
Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2006
53
28
Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from "open and see" to "see and open"
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2014
53
29
Nuclear imaging in cancer theranostics
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2007
52
30
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
52
31
Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2006
51
32
The many ways to myocardial perfusion imaging
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2005
50
33
Advances in cancer therapy with radiolabeled monoclonal antibodies
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2006
50
34
In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2007
50
35
The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2007
50
36
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
50
37
Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2011
50
38
FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2009
49
39
Advances in radioguided surgery in oncology
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2017
48
40
Immunoscore and its introduction in clinical practice
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2020
48
41
Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
48
42
Multimodality imaging of hypoxia in preclinical settings
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2010
47
43
MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
47
44
Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
46
45
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
46
46
Small animal PET in preclinical studies: opportunities and challenges
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2008
46
47
Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2010
46
48
Recent issues on dosimetry and radiobiology for peptide receptor radionuclide therapy
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2011
46
49
Radiolabelled aptamers for tumour imaging and therapy
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2007
45
50
Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions
Quarterly Journal of Nuclear Medicine and Molecular Imaging
2009
45
site/software ©
exaly
; All materials licenced under
CC by-SA
.